Review Article
Systematic Review: Adjuvant Chemotherapy for Locally Advanced Rectal Cancer with respect to Stage of Disease
Table 2
Baseline characteristics of rectal cancer patients in included studies.
| | | Number of patients |
Age |
Male
(%) | Stage II rectal cancer | Stage III rectal cancer | Previous treatment | | | Total | Chemotherapy
(%) | Control
(%) | Chemotherapy
(%) | Control
(%) | Chemotherapy
(%) | Control
(%) | Chemotherapy | Radiotherapy |
| | Glimelius et al. 2005 [11] | 691 | 339
(49) | 352
(51) | 64 versus 66 | NR | 160
(23) | 163
(24) | 179
(26) | 189
(27) | No | No |
| | CCCSGJ 1995 [12] | 761 | 516
(68) | 245
(32) | 57 versus 60 | NR | 229
(30) | 120
(16) | 287
(38) | 125
(16) | No | No |
| Fisher et al.
1988 [13] | 371 | 187
(50) | 184
(50) | 61 versus 61 | 240
(64) | 72
(19) | 67
(18) | 115
(31) | 117
(32) | No | No |
| Kato et al.
2002 [14] | 129 | 66
(51) | 63
(49) | 60.2 versus 61.4 | NR | 26
(20) | 26
(20) | 40
(31) | 37
(29) | No | No |
| Kodaira et al.
1998 [15] | 670 | 331
(49) | 339
(51) | NR | NR | 154
(23) | 162
(25) | 177
(26) | 177
(26) | No | No |
| | Hamaguchi et al. 2011 [16] | 274 | 139
(51) | 135
(49) | 59 versus 58 | 165
(60) | NR | NR | 139
(51) | 135
(49) | No | No |
| | QUASAR 2007 [17] | 817 | 410
(50) | 407
(50) | NR | NR | 410
(50) | 407
(50) | NR | NR | No | No |
| | Sakamoto et al. 2007 [18] | 1814 | 966
(53) | 848
(47) | NR | NR | 377
(21) | 316
(17) | 589
(33) | 532
(29) | No | No |
| | Total | 5527 | 2954
(53) | 2573
(47) | — | — | 1428
(26) | 1261
(23) | 1526
(27) | 1312
(24) | — | — |
|
|
NR: not reported.
|
